Decoding man’s best friend
Genetic data brings CVM researchers closer to targeted treatments for urinary stones in dogs—and humans. Read more
Recognizing US antibiotic awareness week
US Antibiotic Awareness Week (USAAW), held November 18-24, is an annual observance that highlights the steps everyone can take to improve antibiotic prescribing and use. Learn more about what one team at the CVM is doing to mitigate antimicrobial resistance.
Research roundup: Can improved genetic sequencing methods more swiftly tackle emerging disease in swine herds?
A team of researchers in the Department of Veterinary and Biomedical Sciences at the CVM demonstrated that RNA genetic sequencing could be a robust tool for investigating and surveilling emerging viral diseases in swine herds. Read more
CVM researchers are constantly in the process of planning, writing, and submitting grant applications. For NIH grants,they go through a receipt and referral, peer review, and awards process, all of which can take nearly a year. If the process is successful, the researcher’s institution receives a “notice of award” and the researcher receives a congratulatory e-mail. Dr. Mather Kannan has been awarded NIH grants for “MicroRNA Regulation of CD39” and “MicroRNA Regulation of CD38 and Chemokine Genes in Human Airway Smooth Muscle.”
Dr. Bruce Walcheck, professor in the Veterinary and Biomedical Sciences Department; his co-principal investigator, Dr. Dan Kaufman, professor of medicine in the Minnesota Stem Cell Institute; and Bruce's coinvestigator Dr. Jimmy Wu, associate professor in the Veterinary and Biomedical Sciences Department, were recently awarded a National Institutes of Health (NIH) research project grant totaling approximately $2.25 million in total costs over five years.